Johnson & Johnson Agrees To Acquire Shockwave Medical For $335/Share In Cash, Corresponding To An Enterprise Value Of Approximately $13.1B Including Cash Acquired
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has agreed to acquire Shockwave Medical for $335 per share in cash, which corresponds to an enterprise value of approximately $13.1 billion, including cash acquired. This strategic acquisition is expected to significantly enhance Johnson & Johnson's medical device portfolio.
April 05, 2024 | 10:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Johnson & Johnson's acquisition of Shockwave Medical for $13.1 billion is a significant expansion of its medical device portfolio, indicating a strategic move to strengthen its position in the healthcare sector.
The acquisition of Shockwave Medical is a major strategic move for Johnson & Johnson, likely to be viewed positively by investors as it enhances the company's product portfolio and market position in the medical device sector. This could lead to increased investor confidence and potentially a positive impact on JNJ's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Shockwave Medical is being acquired by Johnson & Johnson for $335 per share in cash, representing a significant premium and a total enterprise value of approximately $13.1 billion.
The acquisition price of $335 per share represents a significant premium for Shockwave Medical's shareholders, likely leading to a positive reaction in SWAV's stock price in the short term. This deal highlights the value of Shockwave Medical's technology and products in the healthcare sector.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100